Position in PRQR
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$8,856,781
-$1,965,898 QoQ
Shares Held
5,467,149
+2.0% QoQ
Ownership
3.87%
of shares outstanding
% of Portfolio
1.84%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PRQR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Privium Fund Management B.V. holds $142,100,239 across 32 Biotechnology names. PRQR ranks #4 (6.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
366,936 | $23,006,887 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
290,024 | $21,777,902 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
58,729 | $9,926,375 | |
| 4 | PRQR |
ProQR Therapeutics N.V.
This page
|
5,467,149 | $8,856,781 | |
| 5 | QURE |
uniQure N.V.
|
486,520 | $7,954,602 | |
| 6 | RARE |
Ultragenyx Pharmaceutical Inc.
|
364,802 | $7,642,601 | |
| 7 | ARQT |
Arcutis Biotherapeutics, Inc.
|
320,972 | $7,562,100 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
92,305 | $5,214,309 |
All Filings in PRQR
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-07-15 | $9,786,085 | 5,528,862 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $8,856,781 | 5,467,149 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $10,822,679 | 5,357,762 | Shares | Sole | 2026-02-03 | |
| 2025-12-11 | $13,048,114 | 5,528,862 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $10,646,351 | 4,998,287 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $10,195,026 | 4,997,562 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $6,630,891 | 4,985,633 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $13,211,927 | 4,985,633 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $10,250,946 | 5,632,388 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $9,264,003 | 5,580,725 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $12,238,781 | 5,344,446 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $10,582,003 | 5,344,446 | Shares | Sole | 2024-02-26 | |
| 2023-09-30 | $6,947,779 | 5,344,446 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $8,658,002 | 5,344,446 | Shares | Sole | 2023-07-26 | |
| 2023-03-31 | $11,383,669 | 5,344,446 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $19,774,450 | 5,344,446 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $3,976,267 | 5,344,446 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $4,157,978 | 5,344,446 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $4,746,223 | 5,244,446 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $38,172,928 | 4,765,659 | Shares | Sole | 2022-02-09 | |
| No filing history on record for this holder in this stock. | ||||||